Clinical trials
More than 1.800 newly infected, 14 people died
In the last 24 hours, 12.047 people were tested.
There are 138 people on respirators.
Since the outbreak of the pandemic, 402.700 people have fallen ill with COVID-19 in Serbia, and 4.085 have died.
A total of 2.664.142 people were tested for coronavirus in Serbia by 3 p.m.
Djerlek: It is still early to ease measures
- Read more about More than 1.800 newly infected, 14 people died
- Log in to post comments
42,000 doses of Moderna COVID-19 vaccine expected in Romania on Friday
As many as 42,000 doses of the Moderna COVID-19 vaccine will arrive at the Cantacuzino Military Medicine Research and Development National Institute on Friday, according to the National COVID-19 Vaccination Coordination Committee (CNCAV).
Virus team visits China lab as poorer nations get vaccine boost
International experts on Feb. 3 inspected a Chinese laboratory in Wuhan that some U.S. officials had suggested was the source of the coronavirus, as plans were firmed up to distribute vaccines to poorer nations.
Slovenian-developed vaccine to be designed as spray
Ljubljana – After developing a vaccine against Covid-19 last year, Slovenian researchers will focus on developing a technology to spray the vaccine into the nose or mouth, the head of the research team, Roman Jerala, has revealed for the STA.
EU chief: 60% of bloc to be inoculated by mid-2021
Nearly 500 million doses of the coronavirus vaccine could be made available to European Union member-states by the end of the first semester of 2021, according to the bloc's chief executive, Ursula von der Leyen.
- Read more about EU chief: 60% of bloc to be inoculated by mid-2021
- Log in to post comments
Greece considering restricting Oxford-AstraZeneca vaccine to under-65s
Greece's National Vaccination Committee is considering not giving the Oxford/AstraZeneca vaccine against Covid-19 to people older than 65, Kathimerini understands.
The Greek panel will announce it's decision either today of Thursday.
The Lancet: Russian Sputnik V Vaccine Shown Over 90 Percent Effective
Russia's Sputnik V vaccine was 91.6% effective in preventing people from developing COVID-19, according to peer-reviewed results from its late-stage clinical trial published in The Lancent international medical journal on Tuesday.
Last Say: Data on AstraZeneca Vaccine Effect on Senior Patient Are Insufficient
There is not enough data to say for sure "how well the AstraZeneca/Oxford vaccine would work" in people over 55, and the reason for this is that most of the participants in the manufacturer's preliminary studies are between 18 and 55 years old.
The main topic of the world media is Serbian success with vaccination process
The main topic of the show is the success that Serbia has achieved in terms of procurement of vaccines and immunization of the population.
Brnabic pointed out at the start of the interview that Serbia was involved in the process of procuring vaccines from the very beginning.
Foto: Printskrin
First Moderna vaccine doses to be distributed in Romania on Wednesday
As many as 26,210 doses of the COVID-19 Moderna vaccine will be distributed in Romania on Wednesday to the regional centres nationwide for the immunisation with the first dose of persons appointed for vaccination via the appointment scheduling platform, according to the National COVID-19 Vaccination Coordination Committee (CNCAV).